Emerald Holding, Inc. Files 8-K for August 8 Event

TL;DR

Emerald Holding filed an 8-K on Aug 12 for an Aug 8 event - check for Reg FD/Financials.

AI Summary

Emerald Holding, Inc. filed an 8-K on August 12, 2025, reporting an event on August 8, 2025. The filing pertains to Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Emerald Expositions Events, Inc. and Expo Event Holdco, Inc., is incorporated in Delaware and headquartered in New York, NY.

Why It Matters

This 8-K filing indicates significant corporate events or disclosures by Emerald Holding, Inc. that could impact investors' understanding of the company's current status.

Risk Assessment

Risk Level: low — This filing is a standard 8-K for corporate disclosures and does not appear to contain immediate negative news.

Key Players & Entities

• Emerald Holding, Inc. (company) — Registrant
• August 08, 2025 (date) — Earliest event reported
• August 12, 2025 (date) — Filing date
• Regulation FD Disclosure (disclosure) — Item Information
• Financial Statements and Exhibits (document) — Item Information
• Emerald Expositions Events, Inc. (company) — Former company name
• Expo Event Holdco, Inc. (company) — Former company name
• Delaware (jurisdiction) — State of Incorporation
• New York, New York (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share EEX New York Stock Exchan
• $60.0 million — on of the transaction was approximately $60.0 million plus future contingent payments based o

Filing Documents

• eex-20250808.htm (8-K) — 47KB
• eex-ex99_1.htm (EX-99.1) — 13KB
• img201606797_0.gif (GRAPHIC) — 0KB
• 0001193125-25-178500.txt ( ) — 167KB
• eex-20250808.xsd (EX-101.SCH) — 23KB
• eex-20250808_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On August 8, 2025, Emerald Holding, Inc. (the "Company") through its wholly-owned subsidiary, 17208227 Canada Inc. ("Emerald Canada"), entered into a share purchase agreement with Generis Global Partners Corp. ("Generis Global"), its shareholders and Generis Global Partners Europe GmbH ("Generis Europe" and together with Generis Global, the "Generis Group"), pursuant to which Emerald Canada acquired all of the outstanding share capital of the Generis Group. The purchase price consideration of the transaction was approximately $60.0 million plus future contingent payments based on business performance. A copy of the press release is attached to this report as Exhibit 99.1. The information furnished pursuant to Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 104 Press Release of the Company. Cover Page Interactive Data File (embedded within the inline XBRL document) Cautionary Note Regarding Forward-Looking Statements The information set forth and incorporated by reference in this Current Report on Form 8-K contains certain forward-looking statements regarding the Company and its subsidiaries, including, without limitation, statements regarding our ability to return our business to pre-COVID levels; general economic conditions, or more specifically about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions or future events or performance; the multiple avenues to return to organic growth; expectations regarding interest rates and economic conditions, among others; our guidance with respect to estimated revenues and Adjusted EBITDA; our ability or inability to obtain insurance coverage relating to event cancellations or interruptions; our intention to continue to pay regular quarterly dividends; our ability to successfully identify and acquire acquisition targets; our expectations arising from the ongoing impact of natural disasters, or outbreaks of contagious disease or the potential for infection (including COVID-19) on our business; how we integrate and grow acquired businesses; and how we expand our international operations, among others. In particular, the declaration, timing and amount of any future dividends will be subject to the discretion and approval of the Company's Board of Directors, and will depend on a number of factors. The forward-looking statements contained or incorporated by reference herein are based on management's current expectations as well as estimates and assumptions prepared by management as of the date hereof, and although they are believed to be reasonable, they are inherently uncert

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EMERALD HOLDING, INC. Date: August 12, 2025 By: /s/ David Doft David Doft Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR